American College of Clinical Pharmacy

About the PRN

The ACCP Pulmonary PRN mission is to improve the health of patients affected by pulmonary diseases by fostering practice innovation, supporting outcomes and translational research, and providing high-quality education to patients and practitioners. The Pulmonary PRN vision is to be the society-based organization for advancing pulmonary pharmacy practice, research, and education through collaboration, innovation, and leadership in an effort to optimize patient quality and quantity of life. The Pulmonary PRN interest areas include (but are not limited to) classic restrictive (Asthma) and obstructive (COPD) lung disorders, interstitial lung diseases (ILD), autoimmune lung diseases, supperative lung diseases such as cystic fibrosis and obliterative bronchiolitis, pulmonary alveolar proteinosis, acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), pulmonary arterial hypertension (PAH), advanced lung failure and lung transplantation, mechanical ventilation and extracorporeal membranous oxygenation. The major focus of the Pulmonary PRN is to provide a forum for like-minded practitioners to collaborate in patient care, education, and scholarly activities germane to our interests. All activities that the Pulmonary PRN engages in will be focused on achieving this goal. The Pulmonary PRN fosters multicenter prospective and retrospective research projects to advance the field.